Xu et al. reported that cGAMP induced TREM2 expression, which decreased Aβ deposition and ameliorated cognitive impairments [130], highlighting the therapeutic potential of targeting cGAMP to treat AD. Here, TREM2 is linked to Alzheimer disease.